These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 2879734)

  • 1. The assessment of the beta-blocking activity of urapidil: a new method.
    Jamieson MJ; Jackson SH; Patel SS; Shepherd AM; Galbraith H; Stewart W; Flanagan PH
    Eur J Clin Pharmacol; 1986; 31(2):149-54. PubMed ID: 2879734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alpha adrenergic blocking activity of urapidil in man.
    Jamieson MJ; Shepherd AM; Jackson SH; Patel SS; Flanagan PH; Galbraith H
    Res Commun Chem Pathol Pharmacol; 1988 Nov; 62(2):173-85. PubMed ID: 2908008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of urapidil on responses to phenylephrine, angiotensin and isoprenaline in man.
    Tomlinson B; Renondin JC; Graham BR; Prichard BN
    Eur J Clin Pharmacol; 1991; 41(1):1-3. PubMed ID: 1685992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of urapidil on beta-adrenoceptors of rat atria.
    Verberne AJ; Rand MJ
    Eur J Pharmacol; 1985 Jan; 108(2):193-6. PubMed ID: 2984023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of the antihypertensive drug urapidil with cardiac beta-adrenoceptors in vitro.
    Freissmuth M; Tuisl E; Steurer G; Schütz W
    Eur J Pharmacol; 1984 Sep; 104(1-2):169-72. PubMed ID: 6094208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacodynamic and pharmacokinetic studies on prizidilol and nipradilol (K-351), antihypertensive drugs with combined vasodilator and beta-adrenoceptor blocking actions, in rabbits.
    Kawashima K; Watanabe TX; Sokabe H
    Jpn J Pharmacol; 1984 Dec; 36(4):519-26. PubMed ID: 6151998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of catecholamine effects during hypoglycaemia in man by urapidil and propranolol.
    Petersen KG; Katschker P; Kerp L
    Eur J Clin Pharmacol; 1989; 36(4):351-5. PubMed ID: 2567671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of urapidil, clonidine, prazosin and propranolol on autonomic nerve activity, blood pressure and heart rate in anaesthetized rats and cats.
    Sanders KH; Jurna I
    Eur J Pharmacol; 1985 Apr; 110(2):181-90. PubMed ID: 3987812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vanidilol: a vanilloid-type vasorelaxant and ocular hypotensive beta-adrenoceptor blocker with partial beta-2-agonist activity.
    Sheu MM; Wu BN; Ho WC; Hong SJ; Chen SJ; Lin YT; Chen IJ
    Pharmacology; 1997 Apr; 54(4):211-24. PubMed ID: 9211567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of urapidil on steady-state serum digoxin concentration in healthy subjects.
    Solleder P; Haerlin R; Wurst W; Klingmann I; Mosberg H
    Eur J Clin Pharmacol; 1989; 37(2):193-4. PubMed ID: 2792175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beta 1-adrenoceptor antagonism by urapidil prior to and after the alpha 2-antagonist rauwolscine in anesthetized dogs.
    Rassier ME; Shebuski RJ; Zimmerman BG
    Eur J Pharmacol; 1986 Mar; 122(1):37-43. PubMed ID: 3007177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vasodilating mechanism and response to physiological pressor stimuli of acute doses of carvedilol compared with labetalol, propranolol and hydralazine.
    Tomlinson B; Bompart F; Graham BR; Liu JB; Prichard BN
    Drugs; 1988; 36 Suppl 6():37-47. PubMed ID: 2908303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the beta-adrenoceptor blocking activity of the Class Ic antiarrhythmic drug diprafenone in man.
    Wagner F; Jähnchen E; Trenk D
    Eur J Clin Pharmacol; 1989; 36(6):579-82. PubMed ID: 2570700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beta blockade by oral propranolol and labetalol.
    Cubeddu LX; Carr ME; Fuenmayor NJ
    Clin Pharmacol Ther; 1985 Mar; 37(3):277-83. PubMed ID: 2857602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of 5-HT1A receptors in blood pressure reduction by 8-OH-DPAT and urapidil in cats.
    Sanders KH; Beller KD; Kolassa N
    J Cardiovasc Pharmacol; 1990; 15 Suppl 7():S86-93. PubMed ID: 1702492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of brain 5-HT1A receptors in the hypotensive response to urapidil.
    Kolassa N; Beller KD; Sanders KH
    Am J Cardiol; 1989 Aug; 64(7):7D-10D. PubMed ID: 2569265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of nebivolol, atenolol and propranolol on in vivo cardiovascular and metabolic responses to isoproterenol in dogs.
    Bowden CR; Marchione CS
    J Pharmacol Exp Ther; 1989 Nov; 251(2):599-605. PubMed ID: 2572694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical pharmacology of urapidil.
    Prichard BN; Renondin JC; Tomlinson B
    J Hypertens Suppl; 1988 Dec; 6(2):S13-9. PubMed ID: 2906695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A highly selective beta1-adrenergic blocker with partial beta2-agonist activity derived from ferulic acid, an active component of Ligusticum wallichii Franch.
    Wu BN; Huang YC; Wu HM; Hong SJ; Chiang LC; Chen IJ
    J Cardiovasc Pharmacol; 1998 May; 31(5):750-7. PubMed ID: 9593075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In support of cardiac chronotropic beta 2 adrenoceptors.
    Brown JE; McLeod AA; Shand DG
    Am J Cardiol; 1986 Apr; 57(12):11F-16F. PubMed ID: 3010692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.